title: Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases.
authors: Vascular Biology Laboratory, AU-KBC Research Center, Chennai, India; Center for Biotechnology, Anna University, Chennai, India.
authors: Suvro
authors: S
authors: Chatterjee
mesh_terms: D000818:Animals; D018797:Cell Cycle Proteins / Q000378:metabolism*; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism*; D008297:Male; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; C493181:VASH1 protein, human; C552060:VASH1 protein, rat; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C467498:vascular endothelial growth factor A, rat